as a result of the last-mentioned effects, the use of ergoline derivatives for the treatment of blood circulation disorders, memory problems, sensation problems and the treatment of migraine is no longer permitted in some eu countries because the risks are believed to outweigh any benefits. however, this concern may be unnecessarily suppressing the use of ergoline medications.